Stocktoria
Emergent BioSolutions Inc. EBS
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2006-11-15
Emergent BioSolutions Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| LINDAHL RICHARD S | EVP, Chief Financial Officer | 2026-06-08 | Tax withheld | 3,964 | $8.00 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | 2026-06-08 | Tax withheld | 2,018 | $8.00 |
| Hartzel William | SVP, Bioservices | 2026-06-08 | Tax withheld | 1,741 | $8.00 |
| Williams Paul Anthony | SVP, Products Business | 2026-06-08 | Tax withheld | 694 | $8.00 |
| Dayal Sujata Tyagi | director | 2026-05-01 | Sell | 12,781 | $8.36 |
| DeGolyer Donald W | director | 2026-05-01 | Sell | 14,527 | $8.36 |
| DeGolyer Donald W | director | 2026-05-01 | Sell | 954 | $8.96 |
| Dayal Sujata Tyagi | director | 2026-05-01 | Sell | 980 | $8.94 |
Source: SEC EDGAR filings · CIK 0001367644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.